Evaluating the Impact of a Game (Inner Dragon) on User Engagement Within a Leading Smartphone App for Smoking Cessation: Randomized Controlled Trial
Journal of Medical Internet Research · 30.10.2024 · 26 · e57839
DOI: 10.2196/57839 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 30.10.2024. Verfasst von Justin S White und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA, United States. Hauptthemen laut MEDLINE: Smoking Cessation, Mobile Applications, Smartphone. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
Smartphone apps are a convenient, low-cost approach to delivering smoking cessation support to large numbers of individuals. Yet, the apps are susceptible to low rates of user engagement and retention.
Objective
This study aims to test the effects of a new game module (called Inner Dragon) integrated into Smoke Free (23 Limited), a leading smoking cessation app with established efficacy. The primary outcomes measured user engagement with the app.
Methods
A 2-arm, parallel-group, randomized controlled trial was conducted in the United States with an 8-week follow-up. Adult individuals who smoked ≥1 cigarettes daily and planned to quit smoking within 7 days were recruited and randomized (N=500), with equal allocation. Both groups received free access to the original Smoke Free app with “core” features of its smoking cessation program (eg, a diary and craving log). The treated group received additional access to the integrated Inner Dragon game that incorporated several game mechanics designed to increase user engagement. User engagement outcomes were the number of unique app sessions, average minutes per session, days with a session, and program adherence. Self-reported and verified smoking abstinence and app satisfaction were also assessed. The main analysis estimated the intention-to-treat effect of access to Inner Dragon on each outcome. Further analyses assessed effect modification by participant characteristics and the association of intensity of game use with program adherence and abstinence.
Results
Overall, user engagement was greater for treated versus control participants: they had 5.3 more sessions of Smoke Free (mean 29.6, SD 36.5 sessions vs mean 24.3, SD 37.9 sessions; P=.06), 0.8 more minutes per session (mean 6.9, SD 5.4 min vs mean 6.1, SD 5.2 min; P=.047), and 3.4 more days with a session (mean 14.3, SD 15.3 days vs mean 11.9, SD 14.3 days; P=.03). Program adherence, based on the number of times core features of the original Smoke Free app were used, was higher for treated versus control participants (mean 29.4, SD 41.3 times vs mean 22.6, SD 35.6 times; P=.03). Self-reported 7-day and 30-day point-prevalence abstinence and verified 7-day point-prevalence abstinence at 8 weeks did not significantly differ by study group. The mean repeated 1-day prevalence of quitting was higher among the treated group versus the control group (mean 17.3%, SD 25.6 vs mean 12.4%, SD 21.3; P=.01). App satisfaction and the motivation to (stay) quit did not differ by study group. Higher intensity of game use was associated with increased program adherence and self-reported abstinence.
Conclusions
Findings suggest that the Inner Dragon game increased user engagement and program adherence. Additional refinements to the game design may clarify whether the game increases abstinence rates. Overall, it is feasible to deploy games and gamification to enhance user engagement in existing smoking cessation interventions. Trial Registration ClinicalTrials.gov NCT05227027; https://clinicaltrials.gov/study/NCT05227027
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA, United States.
- Philip R Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA, United States.
- Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, United States.
- Department of Economics, University of Oxford, Oxford, United Kingdom.
- Department of Psychology, Rowan University, Glassboro, NJ, United States.
- Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, United States.
ORCID-Profile: Justin S White, Séverine Toussaert, Bethany R Raiff, Marie K Salem, Amy Yunyu Chiang, David Crane, Edward Warrender, Courtney R Lyles, Lorien C Abroms, J Lee Westmaas, Johannes Thrul
Förderung
- NIA NIH HHS
- NCI NIH HHS
Zitieren
APA
White, J. S., Toussaert, S., Raiff, B. R., Salem, M. K., Chiang, A. Y., Crane, D., Warrender, E., Lyles, C. R., Abroms, L. C., Westmaas, J. L., & Thrul, J. (2024). Evaluating the Impact of a Game (Inner Dragon) on User Engagement Within a Leading Smartphone App for Smoking Cessation: Randomized Controlled Trial. Journal of Medical Internet Research, 26, e57839. https://doi.org/10.2196/57839
Vancouver
White JS, Toussaert S, Raiff BR, Salem MK, Chiang AY, Crane D, et al. Evaluating the Impact of a Game (Inner Dragon) on User Engagement Within a Leading Smartphone App for Smoking Cessation: Randomized Controlled Trial. Journal of Medical Internet Research. 2024;26:e57839. doi:10.2196/57839
BibTeX
@article{White2024,
author = {White, Justin S and Toussaert, Séverine and Raiff, Bethany R and Salem, Marie K and Chiang, Amy Yunyu and Crane, David and Warrender, Edward and Lyles, Courtney R and Abroms, Lorien C and Westmaas, J Lee and Thrul, Johannes},
title = {Evaluating the Impact of a Game (Inner Dragon) on User Engagement Within a Leading Smartphone App for Smoking Cessation: Randomized Controlled Trial},
journal = {Journal of Medical Internet Research},
year = {2024},
volume = {26},
pages = {e57839},
doi = {10.2196/57839}
}
EUVIMED